New Nurse-Led program aims to guide women through advanced breast cancer treatment
NCT ID NCT06983691
Summary
This study is testing a new support program led by nurses for women with advanced HER2+ breast cancer who are taking a specific drug combination. The program aims to help patients better understand their treatment, manage side effects, stick to their medication schedule, and cope with their diagnosis. Researchers want to see if patients find the program helpful and practical to use in their daily lives.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2+ METASTATIC BREAST CANCER (MBC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.